BR Biomedical Reports 2049-9434 2049-9442 D.A. Spandidos BR-20-6-01787 10.3892/br.2024.1787 Articles Prevalence of oral Capnocytophaga species and their association with dental plaque accumulation and periodontal inflammation in middle‑aged and older people ShigeishiHideo 1 HamadaNatsuki 1 KaneyasuYoshino 1 NiitaniYoshie 2 TakemotoToshinobu 2 OhtaKouji 1 Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan Department of Oral Health Management, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan Correspondence to: Dr Hideo Shigeishi, Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami, Hiroshima 734-8553, Japan quan_jmd@126.com shige@hiroshima-u.ac.jp 06 2024 30 04 2024 20 6 99 04 02 2024 29 03 2024 Copyright © 2024, Spandidos Publications 2024

Capnocytophaga species are commonly found in human oral microbiome. The aim of the present study was to understand the association of the prevalence of oral Capnocytophaga species with oral hygiene and periodontal inflammation. A total of 136 patients (median age 72 years) who visited the Hiroshima University Hospital (Hiroshima, Japan) between April 2021 and June 2023 were enrolled. Swab samples were obtained from the tongue surface. DNA from Capnocytophaga species (C. ochracea and C. sputigena) was detected by real-time PCR analysis. Dental plaque accumulation was observed to assess the oral hygiene condition of participants. Additionally, clinical periodontal inflammation was assessed with periodontal inflamed surface area (PISA) scores. Clinical confounding factors such as age, sex, lifestyle-related disease, remaining teeth and denture wearing between Capnocytophaga species-positive and -negative groups were adjusted with a propensity score matching method. Mann-Whitney U and χ2 or Fisher's exact test were employed for statistical analysis. The prevalence rate was 67.6% for oral C. ochracea and 83.1% for C. sputigena. C. ochracea-positive participants showed significantly higher plaque control record scores (an indicator of dental plaque accumulation) than C. ochracea-negative participants (P=0.03). Additionally, C. ochracea/C. sputigena dual-positive participants exhibited significantly higher plaque control record and PISA scores than non-dual-positive participants (P=0.01 and P=0.04, respectively). Propensity score matching was conducted in the C. ochracea/C. sputigena dual-positive group and the non-dual-positive group for adjustment of clinical factors, resulting in 51 matched patient pairs. C. ochracea/C. sputigena dual-positive participants had significantly higher plaque control record scores than non-dual-positive participants (P=0.02). The present results suggest that the prevalence of both oral C. ochracea and C. sputigena is associated with poor oral hygiene in middle-aged and older people.

 Capnocytophaga oral hygiene dental plaque periodontitis real-time PCR dentistry periodontology Funding: The present study was supported by Hiroshima University (No. 0G220). Introduction

Periodontitis is a common infectious disease caused by periodontopathic bacteria with dysbiosis of the oral microbiota (1) and is associated with systemic diseases such as diabetes, cardiovascular disease and adverse pregnancy outcomes (2). For prevention of periodontitis, daily toothbrushing, flossing between teeth, promotion of oral hygiene, professional dental care and regular replacement of toothbrushes to avoid bristle splaying and softening are required (2-5). Among periodontopathic bacteria, ‘red complex’ bacteria such as Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola are major pathogens for chronic periodontitis (6). The periodontal inflamed surface area (PISA) score indicates the severity of clinical periodontal inflammation (7). The prevalence of both T. forsythia and T. denticola has been associated with increased PISA values in older Japanese people (8), suggesting that these bacteria are associated with the severity of periodontitis.

Capnocytophaga species such as C. ochracea and C. sputigena are classified as ‘green complex’ bacteria and are involved in early colonization of the dental biofilm (6). It has been reported that many young children exhibit a high prevalence of oral Capnocytophaga species with or without gingivitis (9). Capnocytophaga species are primarily found in the subgingival plaque of patients with periodontitis (10). Furthermore, Capnocytophaga species are abundantly found in oral squamous cell carcinoma tissue, suggesting that Capnocytophaga may contribute to the development of oral cancer as well as the pathology of periodontitis (11). However, the association between Capnocytophaga species and oral health status indicators such as oral hygiene and periodontal disease has not been fully understood in middle-aged and older people. Therefore, the present study investigated the prevalence of two oral Capnocytophaga species, C. ochracea and C. sputigena, and their association with oral hygiene and periodontitis in middle-aged and older Japanese people.

 Materials and methods <sec> <title>Participants

A total of 136 (43 male, 93 females; median age, 72 years, range 36-91 years) patients attending the Hiroshima University Hospital (Hiroshima, Japan) for supportive periodontal therapy from 2021 April to 2023 June were included. Patients aged ≥20 years attending the Hiroshima University Hospital were included. Patients with cancer receiving chemotherapy or radiotherapy and patients with severe immunodeficiency disease were excluded. Ethical approval for the present cross-sectional study was obtained from the Ethics Committee of Hiroshima University (approval no. E-1115). All participants signed informed consent before participating in the study. Clinical characteristics of participants (age, sex, lifestyle-related diseases, denture wearing and number of remaining teeth) were recorded from their medical records.

 Specimen collection and DNA isolation

The specific anatomical structure of the tongue surface may contribute to the characteristic oral microbiome composition that includes periodontopathic anaerobic bacteria. Therefore, tongue surface bacteria were collected (12). Samples were collected by swabbing the tongue surface using sterilized disposable swab applicators (Orcellex® Brush; Rovers Medical Devices) 10 times, as previously described (12). Immediately after swabbing, the swab brush was soaked in lysis buffer (S1-Lysis Buffer; cat. no. A29790, Invitrogen; Thermo Fisher Scientific, Inc.) in a 15 ml plastic tube (Greiner Bio-One). Total DNA was isolated from the swab samples using PureLink™ Microbiome DNA Purification kit (Invitrogen; Thermo Fisher Scientific, Inc.) as previously described (13).

 Oral examination

In accordance with our previous studies (13,14), dental plaque accumulation was assessed by calculating plaque control record scores. Dental plaque was stained using a microbrush and plaque disclosing solution (PROSPEC®; GC Co., Ltd.), as previously described (14). The participants then rinsed with water and the presence of stained dental plaque was recorded at six areas (mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual and distolingual sites) of individual teeth (13). Plaque control record score (%) was calculated as number of tooth surfaces with stained dental plaque divided by the total number of tooth surfaces. Periodontal pocket depth and bleeding on probing (BOP) was examined in accordance with a previous study (15). PISA and periodontal epithelial surface area (PESA) scores were calculated in accordance with a modification of Nesse's methods as reported by a previous study (16).

 Real-time PCR analysis

The presence of bacterial DNA was examined using a real-time PCR device (Thermal Cycler Dice® Real Time System III; Takara Bio, Inc.). The THUNDERBIRD SYBR qPCR mix (Toyobo Life Science) and specific primer sets (Hokkaido System Science Co., Ltd.) were used for the detection of C. ochracea and C. sputigena DNA. Universal primer for bacterial 16S rRNA gene (Hokkaido System Science Co., Ltd.) was used as a reference primer (8). The PCR amplification protocol was as follows: Initial denaturation at 95˚C for 2 min, followed by 40 cycles of 95˚C for 30 sec, 58˚C for 30 sec and 72˚C for 30 sec, and a final step of 72˚C for 2 min. The following previously described PCR primer sets (8,9) were used: C. ochracea forward, 5'-AGAGTTTGATCCTGGCTCAG-3' and reverse, 5'-GATGCCGTCCCTATATACTATGGGG-3' (accession no. FJ577260) (9); C. sputigena forward, 5'-AGAGTTTGATCCTGGCTCAG-3' and reverse, 5'-GATGCCGCTCCTATATACCATTAGG-3' (accession no. NR_113564) (9) and universal primer for bacterial 16S rRNA gene forward, 5'-CGCTAGTAATCGTGGATCAGAATG-3' and reverse, 5'-TGTGACGGGCGGTGTGTA-3' (8). Two independent experiments were performed.

 Statistical analysis

Data were analyzed with IBM SPSS Statistics, version 24.0 (IBM Corp.). The χ2 or Fisher's exact test were used to analyze associations between two categorical variables. The Mann-Whitney U test was used to compare medians between two dependent groups. Data are presented as median (interquartile range). Adjustment and matching of clinical confounding factors between two groups were conducted by propensity score matching. Propensity scores were estimated by logistic regression using seven clinical factors (age, sex, hypertension, diabetes, dyslipidemia, remaining teeth and denture use). A caliper size was set at 0.25 of the standard deviation of the propensity score. G*Power (version 3.1.9.4, Heinrich-Heine-Universität Düsseldorf) was used to determine the sample size required for the Wilcoxon signed-rank test following propensity score matching. The Wilcoxon signed-rank test was used to compare plaque control record, PISA and PESA scores between two groups. Sample size calculation with an effect size of 0.5, significance level of 0.05 and statistical power of 0.8 (minimum acceptable level) (17) revealed that at least 35 paired participants were required. Additionally, post hoc statistical power analysis of the Wilcoxon signed-rank test was performed from the total sample size, with an effect size of 0.5 and significance level of 0.05 using G*Power. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Prevalence of oral C. ochracea and C. sputigena

The prevalence of oral C. ochracea and C. sputigena was 67.6 and 83.1%, respectively. The associations between Capnocytophaga and clinical characteristics are summarized in Table I. A significant association between C. ochracea prevalence and sex was found. No significant associations were found between the prevalence of C. ochracea and clinical factors such as age, systemic disease, number of remaining teeth or denture use. There was no significant association between C. sputigena prevalence and age, sex, systemic disease, the number of remaining teeth or denture use.

 Association of Capnocytophaga species with oral hygiene and periodontal condition

C. ochracea-positive participants recorded higher plaque control record scores (21.0%) than C. ochracea-negative participants (14.0%; Fig. 1A). A significant difference in plaque control record scores was found between C. ochracea-positive and -negative participants. C. sputigena-positive participants recorded higher plaque control record scores (21.0%) than C. sputigena-negative participants (15.0%; Fig. 1B).

The associations between Capnocytophaga species and periodontal condition are summarized in Table II. C. ochracea-positive participants recorded a higher rate of ≥4 mm periodontal pockets with BOP than C. ochracea-negative participants, but this difference was not significant. There was no significant association between the presence of C. ochracea and ≥6 mm periodontal pockets with BOP. C. ochracea-positive participants recorded higher PISA scores than C. ochracea-negative participants, but this difference was not significant. C. sputigena-positive participants recorded a higher rate of ≥4 mm periodontal pockets with BOP than C. sputigena-negative participants, but this difference was not significant. There was no significant association between presence of C. sputigena and ≥6 mm periodontal pockets with BOP. C. sputigena-positive participants recorded higher PISA scores than C. sputigena-negative participants, but this difference was not significant.

 Association of dual Capnocytophaga species infection with oral hygiene and periodontal condition

The associations between the presence of dual Capnocytophaga species and clinical characteristics are summarized in Table III. No significant association was found between the prevalence of C. ochracea/C. sputigena and clinical factors. C. ochracea/C. sputigena dual-positive participants exhibited significantly higher plaque control record scores (21%) than non-dual-positive participants (14%; Fig. 2). Additionally, C. ochracea/C. sputigena dual-positive participants exhibited significantly higher PISA scores than non-dual-positive participants (Table IV).

 Association between prevalence of dual Capnocytophaga species and oral health status after propensity score matching

Propensity score matching was applied to the C. ochracea/C. sputigena dual-positive and the non-dual-positive group, resulting in 51 matched participant pairs (Table SI). There was no significant difference in PISA or PESA scores between the C. ochracea/C. sputigena dual-positive group and the non-dual-positive group (Table V). C. ochracea/C. sputigena dual-positive participants exhibited significantly higher plaque control record scores (21%) than non-dual-positive participants (14%; Fig. 3). The statistical power was 93% based on 51 matched participants, suggesting that the statistical power was sufficient.

 Discussion

The oral hygiene of Capnocytophaga species-positive participants was poor compared with that of Capnocytophaga species-negative participants in the present study. Another study reported an association between the abundance of Capnocytophaga species and dental plaque accumulation and halitosis (18,19). The concentration of volatile sulfur compounds in the oral cavity is associated with the abundance of C. gingivalis in patients with periodontitis who receive periodontal therapy (20). C. ochracea/C. sputigena were associated with dental plaque accumulation in middle-aged and older people before and after propensity score matching in the present study. C. ochracea plays a key role in the initial phase of dental plaque formation and may be involved in co-aggregation with other bacteria to establish mature dental biofilm (21). These findings indicated that Capnocytophaga species infection may be associated with poor oral hygiene. By contrast, the amount of dental plaque accumulation and calculus is not associated with the prevalence of oral Capnocytophaga in patients aged 7-15 years (22). The prevalence rate of oral Capnocytophaga species is 46% in children (aged 2-6 years) with healthy gingiva, indicating that oral Capnocytophaga infection may be established in young children and is commonly detected in children without gingivitis (9). Further research targeting both young and older people is required to clarify the association between the prevalence of oral Capnocytophaga and oral hygiene status.

The relative abundance of oral Capnocytophaga species is greater in periodontally healthy individuals than in individuals with periodontitis or gingivitis (23). Additionally, the abundance of Capnocytophaga species is lower in patients with severe periodontitis than in those with non-severe periodontitis (23). The prevalence of oral Capnocytophaga species is 87% in healthy individuals and 73% in patients with periodontitis (24). Therefore, patients with periodontitis may be less likely to have oral Capnocytophaga infection than periodontally healthy individuals. Here, Capnocytophaga species were found in 96% of participants receiving supportive periodontal therapy (professional tooth cleaning, scaling and toothbrushing instruction). However, the present study did not compare oral Capnocytophaga prevalence between patients with and without periodontitis.

No association was found between dual infection with C. ochracea/C. sputigena and PISA scores in middle-aged and older people following propensity score matching, suggesting that C. ochracea/C. sputigena was not associated with active periodontitis. Capnocytophaga species are periodontal pathogens that may be associated with stable periodontitis with mild periodontal inflammation, by contrast with P. gingivalis, T. forsythia and T. denticola, which are major periodontal pathogens (6). To the best of our knowledge, there is no standard for employing the PISA value to assess the severity of periodontitis. Leira et al (25) equated active periodontitis with a PISA score >130. The median PISA score of participants in the present study was 55.2 and the maximum score was 958. These findings suggested that many participants in this study had mild periodontitis. Therefore, it was hypothesized that patients with mild periodontitis are more likely to have oral Capnocytophaga infection than those with moderate or severe periodontitis. Additionally, no significant association was found between the presence of Capnocytophaga species and ≥6 mm deep periodontal pockets with BOP (an indicator of severe periodontitis). The prevalence of oral Capnocytophaga species may not be associated with severity of periodontitis. Among Capnocytophaga species, C. gingivalis is associated with periodontal inflammation (26). However, the association between oral C. gingivalis and severity of periodontitis remains unknown. In our previous study, dual infection with T. forsythia and T. denticola was associated with severity of periodontal inflammation in older Japanese people (8). Therefore, it is hypothesized that T. forsythia and T. denticola are more importantly associated with the progression of periodontitis than Capnocytophaga species. To the best of our knowledge however, no previous studies have investigated the association between Capnocytophaga species and T. forsythia /T. denticola.

Oral microbiome diversity is associated with the development and progression of periodontitis (27,28). It is hypothesized that oral microorganisms are cooperatively and synergistically involved in periodontitis, rather than single bacteria alone (27,28). Fusobacterium nucleatum coaggregates with C. ochracea; F. nucleatum-induced dental plaque biofilm formation is enhanced by the soluble component of C. ochracea (29). Such interactions between Capnocytophaga species and other periodontal disease-associated bacteria may contribute to induction of periodontal inflammation. Therefore, it is essential to maintain good oral health with daily toothbrushing, together with regular professional dental care, including dental scaling.

Cleaning the tongue surface as well as brushing the teeth is key for reducing the growth of oral bacteria. The application of topical tetracycline ointment on the tongue surface has been shown to decrease bacterial presence (30), suggesting that topical antibiotic administration is effective in inhibiting bacterial growth on the tongue surface. Notably, previous studies have investigated the effectiveness of adjunct periodontal therapy using ozonized gels, photobiomodulation and probiotics in patients with periodontitis (31-33). However, the effects of such therapies on the bacterial population on the tongue dorsum remain unknown. Additional research is required to elucidate the effects of antibiotic application and adjunct periodontal therapies on microbiota of the tongue surface.

In addition to periodontopathic bacteria, periodontal herpes virus also serves a major role in the pathology of periodontal disease (34). The cytopathic impact of the herpes virus on immune cells may lead to host immune dysfunction (34). Additionally, herpes virus infection in host cells may induce production of inflammatory cytokines and chemokines via activation of signaling pathways such as p38 MAP kinase, JNK and NF-κB (35). Virus-enhanced local inflammatory response may be involved in the progression of periodontitis. Among herpes viruses, the Epstein-Barr virus (EBV) is associated with inflammation (36). Our previous study reported that oral EBV has a prevalence rate of 20% and is associated with PISA and plaque control record scores (37). Additionally, oral human herpesvirus-7 is commonly found in individuals with deep periodontal pockets (38). However, the association between Capnocytophaga species and periodontal herpes virus remains unclear.

There were several limitations in the present study. First, the association between the prevalence of single Capnocytophaga species and oral health status after adjusting for the effect of clinical confounding factors was not investigated. Second, the prevalence of oral Capnocytophaga species positivity in young people without periodontitis remains unclear. Third, the association between Capnocytophaga species other than C. ochracea and C. sputigena and periodontal inflammation remains unclear. Fourth, the presence of Capnocytophaga species in inflammatory periodontal pockets was not elucidated. It is important to demonstrate the presence of Capnocytophaga species in the gingival sulcus to clarify the association between Capnocytophaga species and periodontal inflammation. Fifth, a causal association between the prevalence of oral Capnocytophaga species and dental caries or periodontitis remains uncertain because the present study was a cross-sectional study. Finally, the generalizability of the results is limited because the present study was performed at a single hospital in Japan.

In conclusion, oral Capnocytophaga species were prevalent in middle-aged and older Japanese people with periodontitis. Additionally, dual oral Capnocytophaga species infection (C. ochracea/C. sputigena) may be associated with poor oral hygiene and mild periodontal inflammation.

 Supplementary Material Association between the prevalence of <italic>C. ochracea/C. sputigena</italic> and clinical characteristics after propensity score matching. Acknowledgements

The authors would like to thank Ms Helen Jeays (Edanz; Hiroshima, Japan) for editing the manuscript.

 Availability of data and materials

The data generated in the present study are included in the figures and/or tables of this article.

 Authors' contributions

HS conceived the study, performed experiments, analyzed data and wrote and reviewed the manuscript. NH, YK and YN performed experiments. TT analyzed and interpreted data and supervised the study. KO analyzed and interpreted data and reviewed the manuscript. HS and KO confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

 Ethics approval and consent to participate

The Ethical Committee of Hiroshima University approved the study (approval no. E-1115), and all participants signed informed consent agreement prior to participation.

 Patient consent for publication

Not applicable.

 Competing interests

The authors declare that they have no competing interests.

 References KinaneDFStathopoulouPGPapapanouPNPeriodontal diseasesNat Rev Dis Primers31703820172880520710.1038/nrdp.2017.38 JanakiramCDyeBAA public health approach for prevention of periodontal diseasePeriodontol8420221420203284441210.1111/prd.12337 KaneyasuYShigeishiHSugiyamaMOhtaKDevelopment and evaluation of the ‘Toothbrushing Timer with Information on Toothbrushes’ application: A prospective cohort pilot studyClin Exp Dent Res91206121320233787288710.1002/cre2.797 KaneyasuYShigeishiHOhtaKSugiyamaMChanges in the bristle stiffness of polybutylene terephthalate manual toothbrushes over 3 months: A randomized controlled trialMaterials (Basel)13280220203258030010.3390/ma13122802 KaneyasuYShigeishiHOhtaKSugiyamaMAnalysis of the deflection, bristle splaying, and abrasion of a single tuft of a polybutylene terephthalate toothbrush after use: A randomized controlled trialMaterials (Basel)15489020223588835610.3390/ma15144890 SocranskySSHaffajeeADPeriodontal microbial ecologyPeriodontol3813518720051585394010.1111/j.1600-0757.2005.00107.x NesseWAbbasFvan der PloegISpijkervetFKDijkstraPUVissinkAPeriodontal inflamed surface area: Quantifying inflammatory burdenJ Clin Periodontol3566867320081856414510.1111/j.1600-051X.2008.01249.x ShigeishiHNakamuraMOkaISuCYYanoKIshikawaMKaneyasuYSugiyamaMOhtaKThe associations of periodontopathic bacteria and oral candida with periodontal inflamed surface area in older adults receiving supportive periodontal therapyDiagnostics (Basel)11139720213444133110.3390/diagnostics11081397 HayashiFOkadaMZhongXMiuraKPCR detection of Capnocytophaga species in dental plaque samples from children aged 2 to 12 yearsMicrobiol Immunol45172220011127060210.1111/j.1348-0421.2001.tb01269.x JepsenKFalkWBruneFFimmersRJepsenSBekeredjian-DingIPrevalence and antibiotic susceptibility trends of periodontal pathogens in the subgingival microbiota of German periodontitis patients: A retrospective surveillance studyJ Clin Periodontol481216122720213393438410.1111/jcpe.13468 PereraMAl-HebshiNNPereraIIpeDUlettGCSpeicherDJChenTJohnsonNWInflammatory bacteriome and oral squamous cell carcinomaJ Dent Res9772573220182963084610.1177/0022034518767118 SuCYShigeishiHNishimuraROhtaKSugiyamaMDetection of oral bacteria on the tongue dorsum using PCR amplification of 16S ribosomal RNA and its association with systemic disease in middle-aged and elderly patientsBiomed Rep10707620193058830610.3892/br.2018.1175 OkaIShigeishiHOhtaKCo-infection of oral Candida albicans and Porphyromonas gingivalis is associated with active periodontitis in middle-aged and older Japanese peopleMedicina (Kaunas)5872320223574398610.3390/medicina58060723 KaneyasuYShigeishiHMaeharaTFukada-SambuichiEAmanoHSugiyamaMMeasurement of bristle splaying of toothbrushes using digital imaging and evaluation of plaque removal efficacy over 3 months: A randomized controlled trial (RCT)Int J Dent Hyg1817318120203186831110.1111/idh.12427 ShigeishiHSuCYKaneyasuYMatsumuraMNakamuraMIshikawaMSaitoAOhtaKSugiyamaMAssociation of oral HPV16 infection with periodontal inflammation and the oral microbiome in older womenExp Ther Med2116720213345653410.3892/etm.2020.9598 InoueYHatanakaKYamamotoNHirataTMinabeMYamamotoTNaitoTYamamotoMSatoSIshihataHReference values of periodontal inflamed surface area as a clinical index determined by a multicenter retrospective observational studyJ Japanese Soc Periodontol611591672019 CohenJStatistical Power Analysis for the Behavioral Sciences. 2nd Edition. Hillsdale NJ: Lawrence Erlbaum Associates, Publishers, 1988. SeerangaiyanKvan WinkelhoffAJHarmsenHJMRossenJWAWinkelEGThe tongue microbiome in healthy subjects and patients with intra-oral halitosisJ Breath Res1103601020172887594810.1088/1752-7163/aa7c24 PereiraJVLeomilLRodrigues-AlbuquerqueFPereiraJOAstolfi-FilhoSBacterial diversity in the saliva of patients with different oral hygiene indexesBraz Dent J2340941620122320785810.1590/s0103-64402012000400017 IzidoroCBotelhoJMachadoVReisAMProençaLBarrosoHAlvesRMendesJJNon-surgical periodontal treatment impact on subgingival microbiome and intra-oral halitosisInt J Mol Sci24251820233676883910.3390/ijms24032518 KikuchiYOkamoto-ShibayamaKKokubuEIshiharaKOxyR inactivation reduces the growth rate and oxidative stress defense in Capnocytophaga ochraceaAnaerobe7210246620213467321610.1016/j.anaerobe.2021.102466 MashimaITheodoreaCFThaweboonBThaweboonSScannapiecoFANakazawaFExploring the salivary microbiome of children stratified by the oral hygiene indexPLoS One12e018527420172893436710.1371/journal.pone.0185274 IniestaMChamorroCAmbrosioNMarínMJSanzMHerreraDSubgingival microbiome in periodontal health, gingivitis and different stages of periodontitisJ Clin Periodontol5090592020233679207310.1111/jcpe.13793 IdateUBhatKKulkarniRDKotrashettiVKugajiMKumbarVComparison of culture and polymerase chain reaction-restriction fragment length polymorphism for identification of various Capnocytophaga species from subgingival plaque samples of healthy and periodontally diseased individualsJ Oral Maxillofac Pathol2628720223596817010.4103/jomfp.jomfp_172_21 LeiraYMartín-LancharroPBlancoJ. Periodontal inflamed surface area and periodontal case definition classificationActa Odontol Scand7619519820182912911910.1080/00016357.2017.1401659 DasVVinodVBiswasLKumarABiswasRAn update on possible alternative therapeutics for future periodontal disease managementJ Appl Microbiol134lxac03920233672426110.1093/jambio/lxac039 AbuslemeLDupuyAKDutzanNSilvaNBurlesonJAStrausbaughLDGamonalJDiazPIThe subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammationISME J71016102520132330337510.1038/ismej.2012.174 LafaurieGINeutaYRíosRPacheco-MontealegreMPianetaRCastilloDMHerreraDReyesJDiazLCastilloYDifferences in the subgingival microbiome according to stage of periodontitis: A comparison of two geographic regionsPLoS One17e027352320223599818610.1371/journal.pone.0273523 OkudaTOkudaKKokubuEKawanaTSaitoAIshiharaKSynergistic effect on biofilm formation between Fusobacterium nucleatum and Capnocytophaga ochraceaAnaerobe1815716120122225210010.1016/j.anaerobe.2012.01.001 HayashidaSFunaharaMSekinoMYamaguchiNKosaiKYanamotoSYanagiharaKUmedaMThe effect of tooth brushing, irrigation, and topical tetracycline administration on the reduction of oral bacteria in mechanically ventilated patients: A preliminary studyBMC Oral Health166720162726813710.1186/s12903-016-0224-x ScribanteAGalloSPascadopoliMFraniMButeraAOzonized gels vs chlorhexidine in non-surgical periodontal treatment: A randomized clinical trialOral Dis410.1111/odi.1482920233804775710.1111/odi.14829 ElbayMElbayÜŞKayaEKalkanÖPEffects of photobiomodulation with different application parameters on injection pain in children: A randomized clinical trialJ Clin Pediatr Dent47546220233740834710.22514/jocpd.2023.035 ButeraAMaioraniCGalloSPascadopoliMVenugopalAMaryaAScribanteAEvaluation of adjuvant systems in non-surgical peri-implant treatment: A literature reviewHealthcare (Basel)1088620223562802510.3390/healthcare10050886 SlotsJHerpesviral-bacterial interactions in periodontal diseasesPeriodontol 20005211714020102001779910.1111/j.1600-0757.2009.00308.x MogensenTHPaludanSRMolecular pathways in virus-induced cytokine productionMicrobiol Mol Biol Rev6513115020011123898910.1128/MMBR.65.1.131-150.2001 MaulaniCAuerkariEIMasuliliSLSoerosoYSantosoWDKusdhanyLSAssociation between Epstein-Barr virus and periodontitis: A meta-analysisPLoS One16e025810920213461884310.1371/journal.pone.0258109 ShigeishiHOkaISuCYHamadaNNakamuraMNishimuraRSugiyamaMOhtaKPrevalence of oral epstein-barr virus and Porphyromonas gingivalis and their association with periodontal inflamed surface area: A cross-sectional studyMedicine (Baltimore)101e3128220223631692410.1097/MD.0000000000031282 HamadaNShigeishiHOkaISasakiMKitasakiHNakamuraMYanoKWuCHKaneyasuYMaeharaTAssociations between oral human herpesvirus-6 and -7 and periodontal conditions in older adultsLife (Basel)1332420233683668110.3390/life13020324

Plaque control record score in Capnocytophaga species-positive and -negative participants. (A) C. ochracea (B) C. sputigena. C., Capnocytophaga. *P<0.05.

Plaque control record score in C. ochracea/C. sputigena dual-positive or -negative participants. C., Capnocytophaga. *P<0.05.

Plaque control record score in C. ochracea/C. sputigena dual-positive or -negative participants after propensity score matching. C., Capnocytophaga. *P<0.05.

Association between Capnocytophaga species and clinical characteristics.

  C. ochracea   C. sputigena  
Characteristic Negative (n=44) Positive (n=92) P-value Negative (n=23) Positive (n=113) P-value
Median age, years (IQR) 73.5 (13.5) 72.0 (14.0) 0.27a 72.0 (18.0) 72.0 (14.5) 0.75a
Age, years (%)            
     30-39 (n=2) 1 (2.3) 1 (1.1) 0.16b 0 (0.0) 2 (1.8) 0.98b
     40-49 (n=7) 1 (2.3) 6 (6.5)   1 (4.3) 6 (5.3)  
     50-59 (n=12) 0 (0.0) 12(13)   2 (8.7) 10 (8.8)  
     60-69 (n=33) 12 (27.3) 21 (22.8)   5 (21.7) 28 (24.8)  
     70-79 (n=50) 19 (43.2) 31 (33.7)   9 (39.1) 41 (36.3)  
     80-89 (n=30) 11 (25.0) 19 (20.7)   6 (26.1) 24 (21.2)  
     90-99 (n=2) 0 (0.0) 2 (2.2)   0 (0.0) 2 (1.8)  
Sex (%)            
     Male (n=43) 7 (15.9) 36 (39.1) 0.01c 7 (30.4) 36 (31.9) >0.99c
     Female (n=93) 37 (84.1) 56 (60.9)   16 (69.6) 77 (68.1)  
Hypertension (n=30) 10 (22.7%) 20 (21.7%) >0.99c 5 (21.7%) 25 (22.1%) >0.99c
Diabetes (n=19) 6 (13.6%) 13 (14.1%) >0.99c 4 (17.4%) 15 (13.3%) 0.74c
Dyslipidemia (n=25) 8 (18.2%) 17 (18.5%) >0.99c 5 (21.7%) 20 (17.7%) 0.77c
Median number of teeth (IQR) 25.5 (7.6) 25.0 (7.8) 0.78a 23.0 (10.0) 25.0 (7.5) 0.12a
Denture use (n=54) 18 (40.9%) 36 (39.1%) 0.85c 12 (52.2%) 42 (37.2%) 0.24c

IQR, interquartile range; C., Capnocytophaga.

aMann-Whitney U;

bχ2;

cFisher's exact test.

Association between Capnocytophaga species and periodontal condition.

  C. ochracea   C. sputigena  
Periodontal condition Negative (n=44) Positive (n=92) P-value Negative (n=23) Positive (n=113) P-value
≥4 mm periodontal pocket with BOP (n=65) 17 (38.6%) 48 (52.2%) 0.15a 7 (30.4%) 58 (51.3%) 0.11a
≥6 mm periodontal pocket with BOP (n=29) 9 (20.5%) 20 (21.7%) >0.99a 3 (13%) 26 (23%) 0.41a
Median PISA, mm2 (IQR) 38.9 (74.8) 71.2 (150.9) 0.06b 31.7 (126.2) 60.0 (137.6) 0.13b
Median PESA, mm2 (IQR) 1,005.2 (478.0) 1,036.9 (397.0) 0.14b 913.9 (478.2) 1,038.0 (430.6) 0.15b

IQR, interquartile range; PISA, periodontal inflamed surface area; BOP, bleeding on probing; PESA, periodontal epithelial surface area; C., Capnocytophaga.

aFisher's exact;

bMann-Whitney U test.

Association between the prevalence of C. ochracea/C. sputigena and clinical characteristics.

  C. ochracea/C. sputigena  
Characteristic Negative (n=53) Positive (n=83) P-value
Median age, years (IQR) 74.0 (14.0) 72.0 (14.0) 0.25a
Age, years (%)      
     30-39 (n=2) 1 (1.9) 1 (1.2) 0.32b
     40-49 (n=7) 1 (1.9) 6 (7.2)  
     50-59 (n=12) 2 (3.8) 10 (12.0)  
     60-69 (n=33) 13 (24.5) 20 (24.1)  
     70-79 (n=50) 22 (41.5) 28 (33.7)  
     80-89 (n=30) 14 (26.4) 16 (19.3)  
     90-99 (n=2) 0 (0.0) 2 (2.4)  
Sex (%)      
     Male (n=43) 12 (22.6) 31 (37.3) 0.09c
     Female (n=93) 41 (77.4) 52 (62.7)  
Hypertension (n=30) 12 (22.6%) 18 (21.7%) >0.99c
Diabetes (n=19) 9 (17.0%) 10 (12.0%) 0.45c
Dyslipidemia (n=25) 10 (18.9%) 15 (18.1%) >0.99c
Median number of teeth (IQR) 25.0 (8.5) 25.0 (8.0) 0.55a
Denture use (n=54) 24 (45.3%) 30 (36.1%) 0.37c

IQR, interquartile range; C., Capnocytophaga.

aMann-Whitney U;

bχ2;

cFisher's exact test.

Association between prevalence of C. ochracea/C. sputigena and periodontal condition.

  C. ochracea/C. sputigena  
Periodontal condition Negative (n=53) Positive (n=83) P-value
≥4 mm periodontal pocket with BOP (n=65) 20 (37.7%) 45 (54.2%) 0.08a
≥6 mm periodontal pocket with BOP (n=29) 9 (17.0%) 20 (24.1%) 0.39a
Median PISA, mm2 (IQR) 46.2 (79.9) 82.3 (151.1) 0.04b
Median PESA, mm2 (IQR) 1,006.6 (483.1) 1,038.0 (394.2) 0.09b

IQR, interquartile range; PISA, periodontal inflamed surface area; BOP, bleeding on probing; PESA, periodontal epithelial surface area; C., Capnocytophaga.

aFisher's exact test.

bMann-Whitney U test.

Association between the prevalence of C. ochracea/C. sputigena and periodontal condition after propensity score matching.

  C. ochracea/C. sputigena  
Periodontal condition Negative (n=51) Positive (n=51) P-value
≥4 mm periodontal pocket with BOP (n=50) 20 (39.2%) 30 (58.8%) 0.07a
≥6 mm periodontal pocket with BOP (n=21) 9 (17.6%) 12 (23.5%) 0.63a
Median PISA, mm2 (IQR) 46.2 (76.1) 82.9 (155.0) 0.12b
Median PESA, mm2 (IQR) 1,025.3 (478.2) 1,004.5 (514.1) 0.16b

aFisher's exact;

bWilcoxon signed-rank test. IQR, interquartile range; PISA, periodontal inflamed surface area; BOP, bleeding on probing; PESA, periodontal epithelial surface area; C., Capnocytophaga.